Poor sleep is one of the most common complaints in primary care — and one of the most common reasons UK patients seek prescribed cannabis. According to data from the Project Twenty21 registry, more than 60 percent of enrolled patients report sleep disturbance as a primary or contributing symptom.
The clinical evidence on cannabis and sleep is both extensive and contradictory. It rewards careful reading.
Falling Asleep: The Strongest Evidence
The most consistent finding across studies is that THC reduces sleep onset latency — the time it takes to fall asleep. A 2022 meta-analysis in the Journal of Clinical Sleep Medicine examined 14 studies and found a moderate but statistically significant effect: participants using THC-containing products fell asleep an average of 8 to 12 minutes faster than those on placebo.
For patients whose primary complaint is difficulty getting to sleep — common in anxiety, chronic pain, and PTSD — this effect alone can be clinically meaningful. A patient who lies awake for two hours every night and reduces that to 30 minutes has gained something significant, even if the underlying sleep architecture is unchanged.
CBD's effects on sleep onset are less clear. Some studies suggest a modest benefit; others show no effect. The evidence is strongest for formulations combining THC and CBD, particularly in patients whose sleep disturbance is driven by pain or anxiety rather than a primary sleep disorder.
Sleep Architecture: The Complication
This is where things get complicated. THC reliably suppresses REM sleep — the stage associated with dreaming and memory consolidation. In the short term, this can feel beneficial: less REM sleep often means fewer awakenings and more subjectively restful sleep. In the long term, REM suppression may have consequences, particularly for memory, emotional processing, and cognitive function.
The clinical significance of THC-induced REM suppression remains debated. For some patients — particularly those with PTSD, where excessive REM activity is associated with nightmares — REM suppression may be therapeutic rather than harmful. For others, the long-term effects are less clear, and the research has not followed patients for long enough to provide definitive answers.
Withdrawal from THC after sustained use often produces REM rebound: an increase in REM sleep, sometimes accompanied by vivid dreams or nightmares. This is generally temporary but can be disruptive for patients who discontinue treatment.
What This Means for Patients
The practical implications are straightforward. Cannabis can help you fall asleep and stay asleep. For patients whose sleep is disrupted by pain, anxiety, or hyperarousal — common features of many chronic conditions — night-time cannabis use may represent a genuine therapeutic intervention.
But it is not a neutral intervention. It changes sleep architecture in ways that are not fully understood, and it is probably not a permanent solution for primary insomnia. The most responsible approach — and the one most UK clinicians take — is to use cannabis for sleep as a shorter-term tool within a broader sleep hygiene strategy, not as a lifelong pharmacological crutch.
If you are using prescribed cannabis for sleep, track your outcomes. Note your dose, your timing, and how you feel the next day. The data you collect is the best guide to whether the treatment is working — and whether the benefits are worth the trade-offs that the research is still working to understand.
